Treatment of T1N0 Invasive Breast Carcinoma by Local Excision Implant

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE1/PHASE2

Total Enrollment

45 participants

Study Classification

INTERVENTIONAL

Study Start Date

1997-06-30

Study Completion Date

2013-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate radiation therapy directed to a small region of the breast in women who were recently diagnosed with early stage invasive breast cancer.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Treatment of Stage I and II Carcinoma of the Breast With Mastectomy and Axillary Dissection Versus Excisional Biopsy, Axillary Dissection, and Definitive Irradiation

NCT01468883

Breast Cancer

COMPLETED PHASE3

Lumpectomy Followed By Intraoperative Electron Radiation Therapy (IOERT)

NCT01960803

Invasive Ductal Breast Cancer Carcinoma Breast Stage I

WITHDRAWN NA

Local and Regional Radiotherapy for Nipple Sparing Mastectomy With Implant

NCT05213962

Breast Cancer

ENROLLING_BY_INVITATION

Local Therapy for ER/PR-positive Oligometastatic Breast Cancer

NCT04698252

Breast Cancer

RECRUITING PHASE2

Observational Study of Intra-operative Partial Irradiation of Invasive Ductal Breast Carcinomas With a Good Prognosis

NCT04414202

Invasive Breast Cancer Breast-conserving Surgery

ACTIVE_NOT_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

* When participants undergo surgery to remove the tumor (lumpectomy), it will be followed by the placement of small flexible tubes throughout the region surrounding the site of operation. These tubes will remain in place for 7-9 days following the surgery.
* The first 2-3 days, the tubes will not contain radioactivity. This time is used to do all the calculations necessary for treatment and to check the findings in the breast tissue that was removed. After 2-3 days, the tubes will be filled with a radioactive wire which will remain in place for the next 5 days. During this period of time, participants will be required to remain within the hospital. At the end of these 5 days, the radioactive wires and tubes will be removed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Interstitial Implant Brachytherapy

Via tubes placed at the time of wide local excision delivered over 5 days

Intervention Type RADIATION

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Low risk of multifocal disease within the breast whose tumor location is favorable for brachytherapy catheter placement
* Diagnosis of invasive breast carcinoma (biopsy or fine needle aspiration cytology) and be clinical stage T1N0 (primary tumor \< 2cm, clinically negative nodes)
* Location of primary tumor is not immediately adjacent to the nipple of chest wall
* No evidence of two or more separate tumors within the breast
* All histologic types and pathologic grades of primary tumor
* No extensive intraductal component (substantial intraductal carcinoma away from the primary tumor location)
* No lymphatic or vascular invasion
* Lymph node staging by sentinel node excision or axillary dissection confirms node negative status (If node positive, implant is used to deliver boost to tumor bed)
* Assessment of final surgical margins should be predominantly negative, but a single small region of focal positivity is allowable as it is for whole breast radiation
* 18 years of age or older

Exclusion Criteria

* Tumor is too close to the chest wall to allow placement of catheters
* Contraindications to radiation therapy are present, including a history of scleroderma, systemic lupus or other active connective tissue disease, pregnancy, or prior chest wall radiation

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No